Previous 10 | Next 10 |
2024-02-14 13:54:31 ET More on Mid-day movers & stocks. Financial information for Brera Holdings PLC Financial information for Datasea Seeking Alpha’s Quant Rating on Tenon Medical Historical earnings data for Tenon Medical Financial inform...
Cogent Biosciences, Inc. (NASDAQ: COGT) is one of today's top gainers. The company's shares have moved 60.44% on the day to $8.76. Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes ...
2024-02-14 09:31:30 ET DENVER, Colo., Feb. 14, 2024 ( www.247marketnews.com )- Cogent Biosciences, Inc. (NASDAQ: COGT ) reported, this morning, that it entered into a securities purchase agreement for a private investment in public equity financing in which Cogent will sell ...
2024-02-14 09:16:40 ET More on Cogent Biosciences Citi starts Cogent Biosciences at buy, cites GI tumor drug potential AIM stock dips amid mixed results for post-COVID fatigue therapy Seeking Alpha’s Quant Rating on Cogent Biosciences Historical earnin...
Pro-forma cash, cash equivalents and marketable securities expected to fund the Company into 2027 and through clinical readouts from ongoing SUMMIT, PEAK and APEX registration-directed trials Cogent to host investor webcast at 8:00 a.m. ET on February 23 to review the SUMMIT P...
2024-02-08 14:11:11 ET More on Cogent Biosciences AIM stock dips amid mixed results for post-COVID fatigue therapy Cogent Biosciences issues study updates on bezuclastinib, CGT4859 Seeking Alpha’s Quant Rating on Cogent Biosciences Historical earnings ...
2024-02-08 11:37:46 ET More on Agios Pharmaceuticals, AIM ImmunoTech, etc. CVS Health Corporation (CVS) Q4 2023 Earnings Call Transcript CVS Health FY23 Earnings: Downgrades Inevitable, Long Term Outlook In The Balance CVS Health Corporation 2023 Q4 - Results - Earni...
WALTHAM, Mass. and BOULDER, Colo., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced its upcoming posters for bezuclastinib at the 2024 American Aca...
2024-02-02 17:07:29 ET Gainers: Chenghe Acquisition ( CHEA ) +58% . Leslie's ( LESL ) +6% . Office Properties Income Trust ( OPI ) +4% . Tactile Systems Technology ( TCMD ) +4% . Big 5 Sporting Goods ( BGFV ) +3% . Losers: ...
2024-01-14 09:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
News, Short Squeeze, Breakout and More Instantly...
Cogent Biosciences Inc Com Company Name:
COGT Stock Symbol:
NASDAQ Market:
SUMMIT, PEAK and APEX registration-directed clinical trial enrollment remains on track; topline results expected from all three studies in 2025 Ended 1Q 2024 with $435.7 million in cash, sufficient to fund operations into 2027 WALTHAM, Mass. and BOULDER, Colo., May 07, 2024 (GLOBE...
U.S. stock futures were higher this morning, with the Dow futures gaining over 200 points on Monday. Shares of Marinus Pharmaceuticals, Inc. (NASD...
WALTHAM, Mass. and BOULDER, Colo., April 09, 2024 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced new preclinical data from the Company’s potent, selective,...